are there any over the counter glp 1 Diet Works GLP-1 Companion, 60 CT and turmeric extract standardized to 95% curcuminoids Have you used GLP-1 drugs?

Tomas E, Habener JF

These factors must be taken into account when assessing the balance of benefits and risks for using GLP-1 medications, he said

Key findings from published and presented studies include: In a phase 2 obesity trial, higherdose retatrutide produced average weight loss of around 22.824.2% over 48 weeks in people with obesity. In participants with type 2 diabetes, retatrutide achieved substantial weight loss and marked improvements in blood sugar and cardiometabolic markers, though average percentage weight loss was somewhat lower than in nondiabetic obesity cohorts. Early studies also reported significant reductions in liver fat and visceral adipose tissue, with a high proportion of participants with fatty liver disease showing resolution of hepatic steatosis at higher doses. These results have led several reviews to describe retatrutide as a potential game changer in obesity pharmacotherapy, representing the first GLP1/GIP/glucagon triple agonist with robust human data. Popular coverage has highlighted phase 3 data suggesting average weight losses approaching 29% of body weight in some cohorts (roughly 71 pounds), which is about double typical results with semaglutide over comparable periods

Booking a consultation at Pure Medical Spa allows you to work with experienced providers focused on safe, effective GLP-1 therapy